Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Catalys Pacific is a venture capital firm focused on healthcare innovation, founded to improve patient lives through the development of biotech companies. Established with a significant presence in both Japan and the United States, the firm utilizes a global network to access unique investment opportunities. Catalys Pacific is recognized as one of Japan's largest life sciences-focused investment firms, although specific quantitative metrics such as fund size or portfolio count are not disclosed.
The firm emphasizes transpacific partnerships, targeting both outbound and inbound opportunities to maximize therapeutic impact for patients. This approach not only enhances their investment strategy but also aims to provide attractive returns for investors. Catalys Pacific's commitment to addressing unmet medical needs positions it as a compelling partner for organizations in the healthcare innovation space.
Catalys Pacific invests primarily in early-stage biotech companies within the healthcare sector. The firm emphasizes transpacific partnerships to enhance its investment strategies, which allows them to target both outbound and inbound opportunities. This dual approach aims to maximize therapeutic impact for patients while ensuring attractive returns for investors.
The firm is particularly interested in companies that are developing innovative solutions to pressing healthcare challenges. Catalys Pacific seeks to partner with founders who demonstrate a strong commitment to improving patient outcomes and who possess a clear vision for their company's growth. Their investment strategy is designed to support the development of novel therapies and technologies that can significantly impact patient care.
Catalys Pacific's portfolio includes several notable projects that reflect its focus on healthcare innovation:
These companies exemplify Catalys Pacific's commitment to addressing critical healthcare needs through innovative biotech solutions.
BT Slingsby, MD, PhD, MPH - Founder & Managing Director. He has extensive experience in healthcare and biotech, having led numerous successful investments in the sector.
Takeshi Takahashi, MBA - Managing Director. He brings a strong background in business management and investment strategy, particularly in the Asian markets.
Jay Shepard - Venture Partner. He has a wealth of experience in venture capital and has been involved in several notable biotech investments.
Jon Congleton - Operating Partner. He specializes in operational support for portfolio companies, ensuring they have the resources needed for growth.
Neal Fowler, MBA - Operating Partner. He focuses on strategic development and scaling of biotech ventures.
Ashwin Ram, MD - Partner. He has a medical background and expertise in healthcare investments.
Sandy Mong, MD - Partner. She brings clinical experience and insights into patient needs and healthcare solutions.
Ryutaro Shimazaki - Partner. He has a strong focus on the Japanese market and its unique healthcare challenges.
Yoshiro Banno, MPH - Principal. He supports investment analysis and portfolio management.
Matt Sanders, MBA, JD, Tax LLM - Vice President. He provides legal and financial expertise to the firm.
Yuki Makihira - Vice President. He focuses on market analysis and investment opportunities.
Maki Haginoya - Vice President. She supports operational initiatives within the firm.
Ariel Miura - Analyst. He assists in research and due diligence for potential investments.
Ryan Drant - Advisor. He provides strategic insights based on his extensive experience in the biotech sector.
Nobuo Hanai, PhD - Advisor. He offers scientific expertise and guidance on biotech innovations.
Jonathan MacQuitty, PhD - Advisor. He specializes in research and development strategies for biotech companies.
Masato Iwasaki, PhD - Advisor. He provides insights into the Japanese biotech landscape.
Seth H Z Fischer - Advisor. He has a strong background in venture capital and investment strategies.
Norihiko Ishihara - Advisor. He offers expertise in market entry strategies for biotech firms.
Submit your pitch through their website's contact form for consideration.
What are Catalys Pacific's investment criteria?
Catalys Pacific focuses on early-stage biotech companies within the healthcare sector. They prioritize investments that emphasize transpacific partnerships and aim to address unmet medical needs.
How can I apply or pitch to Catalys Pacific?
Founders interested in pitching to Catalys Pacific should prepare a detailed presentation that outlines their business model, market opportunity, and therapeutic impact. They can reach out through the contact forms available on the firm's website.
What makes Catalys Pacific different from other investors?
The firm distinguishes itself through its strong emphasis on transpacific partnerships, allowing it to leverage unique investment opportunities across both Japan and the United States. This global perspective enhances their investment strategies and potential returns.
What is the geographic scope of Catalys Pacific's investments?
Catalys Pacific operates globally, with a significant focus on North America and Asia, particularly Japan. This geographic diversity allows them to access a wide range of innovative biotech opportunities.
What is Catalys Pacific's post-investment involvement like?
The firm actively supports its portfolio companies through mentorship, operational guidance, and strategic advice. They aim to foster growth and ensure that their investments achieve their therapeutic goals.
What is the typical check size for investments?
While specific check sizes are not disclosed, Catalys Pacific primarily invests in early-stage rounds, including pre-seed, seed, and seed+ (extension) stages, which typically involve smaller investment amounts compared to later-stage funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.